Russell W. Jenkins

Also affiliated with Harvard University, Medical University of South Carolina, Massachusetts General Hospital, MUSC Hollings Cancer Center, Center for Cancer Research, Massachusetts Institute of Technology

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Targeting TBK1 to overcome resistance to cancer immunotherapy”.

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Journal of Clinical Investigation(2020)10.1172/jci135038

N/A

1.9DataRank · unranked

75 citations

Andrew Portell, Elena V. Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan Greene +23 more

Treatment of Advanced Melanoma in 2020 and Beyond

Journal of Investigative Dermatology(2020)10.1016/j.jid.2020.03.943

N/A

0.875DataRank · unranked

341 citations

David E. Fisher, Russell W. Jenkins

Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3841

N/A

0.704DataRank · unranked

108 citations

Samantha Guinn, Filippo Birocchi, Adam Kuo, Yi Sun, Rebecca C. Larson +34 more

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Cell(2024)10.1016/j.cell.2024.03.027

N/A

0.686DataRank · unranked

96 citations

Harrison B. Chong, Siwen Zhang, Tzu-Yi Yang, Matthew J. Lazarov, Stefan Harry +66 more

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids

Cancer Immunology Research(2025)10.1158/2326-6066.cir-23-1011

N/A

0.530DataRank · unranked

15 citations

Luke Maggs, Apekshya Panda, Samuel J. Wright, Angelina M. Cicerchia, Anne Jenney +23 more

Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0071

N/A

0.515DataRank · unranked

30 citations

Giulia Cattaneo, Shahrzad Arya, Jingyu Jia, Maria Chiara Gelmi, Yi Sun +11 more

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102210

N/A

0.382DataRank · unranked

9 citations

Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson +50 more

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579184

N/A

0.290DataRank · unranked

5 citations

Angelina M. Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Joshua Park +48 more

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.02.478819

N/A

0.269DataRank · unranked

5 citations

Marijana Ručević, Emmett Sprecher, Milan Parikh, Jiajia Chen, Dennie T. Frederick +23 more

Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.05.652090

N/A

0.106DataRank · unranked

1 citations

Mounica Vallurupalli, Sarah Noel, Gail Schor, YuhJong Liu, Celeste Nobrega +29 more

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics

Communications Biology(2021)10.1038/s42003-020-01625-6

N/A

0DataRank · unranked

368 citations

Ajaykumar Vishwakarma, Andrew P. Voigt, Andrew M. Bellizzi, Jacob Kaplan, Kenneth G. Nepple +5 more

Overcoming Resistance Mechanisms to Melanoma Immunotherapy

American Journal of Clinical Dermatology(2024)10.1007/s40257-024-00907-7

N/A

0DataRank · unranked

19 citations

David J. Bozym, Giuseppe Tarantino, Ryan J. Sullivan, David Liu, Russell W. Jenkins +1 more

Emerging roles of TBK1 in cancer immunobiology

Trends in cancer(2024)10.1016/j.trecan.2024.02.007

N/A

0DataRank · unranked

19 citations

Carl A. Shirley, Russell W. Jenkins, Alex Miranda

Real-world data confirms limited efficacy of dual programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 immune checkpoint blockade in acral lentiginous melanoma

British Journal of Dermatology(2024)10.1093/bjd/ljae445

N/A

0DataRank · unranked

2 citations

Russell W. Jenkins, David X. Zheng

Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3116

N/A

0DataRank · unranked

0 citations

Neal P. Smith, Moshe Sade-Feldman, Dennie T. Frederick, Russell W. Jenkins, Justine V. Cohen +13 more

Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity

Molecular Therapy(2025)10.1016/j.ymthe.2025.08.028

N/A

0DataRank · unranked

4 citations

Lisa Nieland, Sanne M. van de Looij, Alexandra J E M de Reus, Charles Couturier, Chadi A. El Farran +19 more

Protocol for the preparation and analysis of patient-derived organotypic tumor spheroids

STAR Protocols(2025)10.1016/j.xpro.2025.104286

N/A

0DataRank · unranked

1 citations

Russell W. Jenkins, Or‐Yam Revach, Claire A. Palin

Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease

Neurobiology of Disease(2025)10.1016/j.nbd.2025.107147

N/A

0DataRank · unranked

1 citations

Kyra N. Hermanson, Justin M. Snider, Aki Hara, Brandon K Dahl, Janet Allopenna +9 more

Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer

Expert Opinion on Therapeutic Targets(2025)10.1080/14728222.2025.2545845

N/A

0DataRank · unranked

1 citations

Marco Ventin, Luke Maggs, Yi Sun, Cristina R. Ferrone, Russell W. Jenkins +1 more

371 Lymphotoxin-driven cancer cell eradication by tumoricidal CD8+ TIL

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0371

N/A

0DataRank · unranked

0 citations

Aiping Jiang, Aonkon Dey, Joseph Dean, Jonathan Perera, Genevieve M. Boland +9 more

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy

Neuro-Oncology(2025)10.1093/neuonc/noaf288

N/A

0DataRank · unranked

0 citations

Samuel J. Steuart, Baolin Liu, Hongyan Xie, Derek Effiom, Aleigha Lawless +18 more

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity

Science(2024)10.1126/science.adl6173

N/A

0DataRank · unranked

93 citations

Hiroshi Kondo, Ashwin V. Kammula, Lei Shi, Yi Xiao, Sofiene Dhiab +33 more